BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 27 filers reported holding BIOLINERX LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | 0.0% | 2,000 | -12.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 2,275 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 2,275 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 2,275 | +13.8% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -77.8% | 2,000 | -77.8% | 0.00% | – |
| Q4 2017 | $9,000 | +50.0% | 9,000 | +80.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -20.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -89.1% | 5,000 | -87.5% | 0.00% | -100.0% |
| Q3 2016 | $46,000 | +43.8% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $32,000 | -22.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $41,000 | -10.9% | 40,000 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $46,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,451,000 | $3,236,000 | 2.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 600,000 | $1,338,000 | 0.30% |
| BVF INC/IL | 800,000 | $1,784,000 | 0.28% |
| Senvest Management, LLC | 1,549,805 | $3,456,000 | 0.27% |
| SABBY MANAGEMENT, LLC | 1,902,800 | $4,243,000 | 0.24% |
| Perceptive Advisors | 179,041 | $399,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $2,531,000 | 0.03% |
| Benchmark Capital Advisors | 20,000 | $45,000 | 0.03% |
| JANE STREET GROUP, LLC | 59,063 | $130,000 | 0.00% |
| Virtu KCG Holdings LLC | 18,640 | $41,000 | 0.00% |